Comparative analysis and interpretation of NCCN, NICE and ESMO guidelines for colorectal cancer

王贵玉

doi:10.3969/j.issn.1007-3969.2015.11.002

您当前的位置：

首页 >

文章列表页 >

Comparative analysis and interpretation of NCCN, NICE and ESMO guidelines for colorectal cancer

更新时间：2025-12-31

- Comparative analysis and interpretation of NCCN, NICE and ESMO guidelines for colorectal cancer
- China Oncology Vol. 25, Issue 11, Pages: 849-853(2015)
- 作者机构：
  
  哈尔滨医科大学附属第二医院结直肠肿瘤外科，哈尔滨医科大学大肠癌研究所,黑龙江,哈尔滨,150086
- 作者简介：
- 基金信息：
- DOI：10.3969/j.issn.1007-3969.2015.11.002
  CLC：
- Published Online：01 February 2016，
  
  Published：01 February 2015
- 稿件说明：
移动端阅览
王贵玉. 结直肠癌NCCN、NICE及ESMO指南的对比分析和解读[J]. 中国癌症杂志, 2015, 25(11): 849-853.

王贵玉. Comparative analysis and interpretation of NCCN, NICE and ESMO guidelines for colorectal cancer[J]. China Oncology, 2015, 25(11): 849-853.
王贵玉. 结直肠癌NCCN、NICE及ESMO指南的对比分析和解读[J]. 中国癌症杂志, 2015, 25(11): 849-853. DOI： 10.3969/j.issn.1007-3969.2015.11.002.

王贵玉. Comparative analysis and interpretation of NCCN, NICE and ESMO guidelines for colorectal cancer[J]. China Oncology, 2015, 25(11): 849-853. DOI： 10.3969/j.issn.1007-3969.2015.11.002.

摘要

结直肠癌的规范化治疗是患者得到正确合理治疗的一个重要保障。国外有很多重要诊断治疗指南指导结直肠癌的规范化治疗，其中影响力最大的指南分别是结直肠癌NCCN指南、ESMO指南和NICE指南。NCCN指南是由美国牵头制定的极具影响力的规范化治疗指南，ESMO指南是由欧洲肿瘤内科学会颁布，NICE指南是由英国国家卫生与临床优化研究所发布的成人结直肠癌诊断和管理临床实践指南。这三个指南在结直肠癌的诊断和治疗上存在着一些共同和不同之处，拟就其中的一些关注点进行分析解读，希望对我国的结直肠癌规范化治疗能起到一些参考借鉴作用。

Abstract

It is important for patients with colorectal cancer to receive standard and reasonable treatment. There are many clinical practice guidelines for diagnosis and treatment of colorectal cancer. However

the most influential guidelines are NCCN

ESMO and NICE guidelines. NCCN guidelines are the most world-renowned guidelines from National Comprehensive Cancer Network of the United States; ESMO guidelines are promulgated by the European Society for Medical Oncology; NICE guidelines are guidance of diagnosis and management for colorectal cancer issued by the National Institute for Health and Care Excellence of the United Kingdom. They are very similar in case management and treatment principles. However

there are still some differences in indications for drugs

treatment of hereditary colorectal cancer

laparoscopy indication and management of ileus. Here we discuss some of these differences and provide a reference for standardization of colorectal cancer treatment in China.

关键词

Keywords

references

Views

5995

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Targeted therapy and immunotherapy combined with chemotherapy bring effective response to AFP positive colon cancer patients: a case report and literature review

Mechanisms underlying tepoxalin-mediated regulation of cell growth and chemoresistance via ABCB1 in colorectal cancer

Research progress and prospects of exercise intervention in comprehensive management of colorectal cancer

Advances and future perspectives of neoadjuvant immunotherapy in colorectal cancer

The impact of participation status on the colorectal cancer incidence, stage and survival outcomes in the Shanghai colorectal cancer screening program

Related Author

LIU Miao

LI Jinze

WU Chensi

ZHANG Fengbin

GAO Hongsheng

ZHANG Ruixing

Zhijun HE

Liwen JIN

Related Institution

Department of Pathology, the Fourth Hospital of Hebei Medical University

Department of Gastroenterology, the Fourth Hospital of Hebei Medical University

Department of Oncology, Shanghai Pudong New District Zhoupu Hospital

Cancer Institute, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University

Department of Gastroenterology, Shanghai Pudong New District Zhoupu Hospital

AI问答

⁰